HSP2MAG-63K

MILLIPLEX^® Human Sepsis Magnetic Bead Panel 2 - Immune Response Multiplex Assay

Inflammation/Immunology Bead-Based Multiplex Assays using the Luminex technology enables the simultaneous analysis of multiple sepsis biomarkers in human serum, plasma and cell culture samples.

• Codice UNSPSC: 12161503
• eCl@ss: 32161000
• NACRES: NA.84

Proprietà

• Livello qualitativo: 200
• Reattività contro le specie: human
• Produttore/marchio commerciale: Milliplex^®
• assay range: accuracy: 87%; (MIP-1β); accuracy: 92%; (MIP-1α); accuracy: 95%; (Granzyme B); accuracy: 98%; (IL-8); standard curve range: 10-10,000 pg/mL; (IL-1α and MIP-1β); standard curve range: 195-200,000 pg/mL; (MMP-8); standard curve range: 2,930-3,000,000 pg/mL; (HSP70); standard curve range: 2-2,000 pg/mL; (Granzyme B); standard curve range: 5-5,000 pg/mL; (IL-8 and MIP-1β)
• tecniche: multiplexing: suitable
• Metodo di rivelazione: fluorometric (Luminex xMAP)
• Condizioni di spedizione: wet ice

Descrizione

Descrizione generale

Sepsis or SIRS (systemic inflammatory response syndrome) results from infection, whether bacterial, viral, fungal, or parasitic. According to the CDC, sepsis is the second leading cause of death in non-coronary ICU patients in the U.S. The pathogenesis of sepsis is very complex. Both an innate and acquired immune response to infection interrupts homeostasis with a shift of cytokine expression that increases immunosuppression. In addition, migration of the leukocytes in the inflamed tissues secretes a tissue factor leading to the formation of thrombin, also triggering the release of chemokines and adhesion molecules through endothelial cells. Severe sepsis occurs when hypotension or hypoperfusion to one or more organs leads to organ dysfunction, which, in turn, can cause septic shock, multiple organ dysfunction syndrome (MODS) and death.

MILLIPLEX^® Human Sepsis Panel 2 is to be used for the simultaneous quantification of any or all of the following analytes in human serum, plasma and cell / tissue culture supernatant samples: Granzyme B, HSP70, IL-1α, IL-8/CXCL8, MIP-1α/CCL3, MIP-1β/CCL4, MMP-8. This kit uses a 96-well format, contains a lyophilized standard cocktail, two internal assay quality controls and can measure up to 38 samples in duplicate.

The Luminex^® xMAP^® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.

Panel Type: Immune Response

Applicazioni

• Analytes: Granzyme B, HSP70, IL-1α, IL-8, MIP-1α, MIP-1β, MMP-8
• Recommended Sample type: Serum, plasma, or cell culture supernatant
• Recommended Sample dilution: Neat
• Assay Run Time: One day Research Category: Inflammation & Immunology

Caratteristiche e vantaggi

Design your multiplex kit by choosing available analytes within this panel.

Altre note

Sensitivity: Refer to kit protocol for individual sensitivities.

Note legali

Luminex is a registered trademark of Luminex Corp

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

xMAP is a registered trademark of Luminex Corp

Informazioni sulla sicurezza

• Pittogrammi: GHS06,GHS08,GHS05,GHS09
• Avvertenze: Danger
• Indicazioni di pericolo: H302 + H332,H311,H317,H318,H373,H411
• Consigli di prudenza: P273 - P280 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338 - P314
• Classi di pericolo: Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
• Organi bersaglio: Respiratory Tract
• Codice della classe di stoccaggio: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects